MedKoo Cat#: 562951 | Name: Pyrintegrin
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pyrintegrin is a cell-permeable promoter of the adhesion of individually dissociated hESCs on matrigel- or laminin-, but not gelatin-coated surfaces, substantially reducing trypsinization-induced apoptosis. Pyrintegrin is known to promote embryonic stem cells survival, is robustly adipogenic and induces postnatal adipose tissue formation in vivo of transplanted adipose stem/progenitor cells (ASCs) and recruited endogenous cells. In vitro, Pyrintegrin stimulated human adipose tissue derived ASCs to differentiate into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARγ) and CCAAT/enhancer-binding protein-α (C/EBPα), with differentiated cells increasingly secreting adiponectin, leptin, glycerol and total triglycerides.

Chemical Structure

Pyrintegrin
Pyrintegrin
CAS#1228445-38-2

Theoretical Analysis

MedKoo Cat#: 562951

Name: Pyrintegrin

CAS#: 1228445-38-2

Chemical Formula: C23H25N5O3S

Exact Mass: 451.1678

Molecular Weight: 451.54

Elemental Analysis: C, 61.18; H, 5.58; N, 15.51; O, 10.63; S, 7.10

Price and Availability

Size Price Availability Quantity
25mg USD 350.00 2 Weeks
50mg USD 550.00 2 Weeks
100mg USD 950.00 2 Weeks
200mg USD 1,450.00 2 Weeks
500mg USD 2,850.00 2 Weeks
1g USD 3,750.00 2 Weeks
2g USD 6,250.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
Synonym
Pyrintegrin; PTN;
IUPAC/Chemical Name
N-Cyclopropylmethyl-4-[4-(6-hydroxy-3,4-dihydro-2H-quinolin-1-yl)-pyrimidin-2-ylamino]-benzenesulfonamide
InChi Key
QRJTZIJWDLJKQO-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H25N5O3S/c29-19-7-10-21-17(14-19)2-1-13-28(21)22-11-12-24-23(27-22)26-18-5-8-20(9-6-18)32(30,31)25-15-16-3-4-16/h5-12,14,16,25,29H,1-4,13,15H2,(H,24,26,27)
SMILES Code
O=S(C1=CC=C(NC2=NC=CC(N3CCCC4=C3C=CC(O)=C4)=N2)C=C1)(NCC5CC5)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
Pyrintegrin significantly boosts human embryonic stem cell (hESC) survival by over 30-fold at a concentration of 2 µM. It enhances integrin-dependent hESC attachment to various extracellular matrices like Matrigel™ and laminin, all while not notably affecting cell proliferation. Pyrintegrin also intensifies the binding of the activated β1 integrin-specific antibody HUTS-21 and amplifies the phosphorylation of several growth factor receptors along with their downstream kinases, such as PI3K and MAPK.
In vitro activity:
Pyrintegrin stimulated human adipose tissue derived ASCs to differentiate into lipid-laden adipocytes by upregulating peroxisome proliferator-activated receptor (PPARγ) and CCAAT/enhancer-binding protein-α (C/EBPα), with differentiated cells increasingly secreting adiponectin, leptin, glycerol and total triglycerides. Reference: Sci Rep. 2017 Jan 27;7:36402. doi: 10.1038/srep36402. https://pubmed.ncbi.nlm.nih.gov/28128224/
In vivo activity:
Pyrintegrin protected mice from LPS-induced podocyte foot process effacement and proteinuria. Cotreatment with pyrintegrin prevented LPS-induced reduction of active β1 integrin in the podocytes. In rats, pyrintegrin reduced peak proteinuria caused by puromycin aminonucleoside-induced nephropathy. Reference: J Am Soc Nephrol. 2015 Nov;26(11):2741-52. https://pubmed.ncbi.nlm.nih.gov/25858967/
Solvent mg/mL mM
Solubility
DMF 50.0 110.73
DMSO 30.0 66.44
Ethanol 1.0 2.21
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 451.54 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Shah BS, Chen M, Suzuki T, Embree M, Kong K, Lee CH, He L, Xiang L, Ahn JA, Ding S, Mao JJ. Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells. Sci Rep. 2017 Jan 27;7:36402. doi: 10.1038/srep36402. PMID: 28128224; PMCID: PMC5269584. 2. Lee HW, Khan SQ, Faridi MH, Wei C, Tardi NJ, Altintas MM, Elshabrawy HA, Mangos S, Quick KL, Sever S, Reiser J, Gupta V. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J Am Soc Nephrol. 2015 Nov;26(11):2741-52. doi: 10.1681/ASN.2014090859. Epub 2015 Apr 9. PMID: 25858967; PMCID: PMC4625676.
In vitro protocol:
1. Shah BS, Chen M, Suzuki T, Embree M, Kong K, Lee CH, He L, Xiang L, Ahn JA, Ding S, Mao JJ. Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells. Sci Rep. 2017 Jan 27;7:36402. doi: 10.1038/srep36402. PMID: 28128224; PMCID: PMC5269584. 2. Lee HW, Khan SQ, Faridi MH, Wei C, Tardi NJ, Altintas MM, Elshabrawy HA, Mangos S, Quick KL, Sever S, Reiser J, Gupta V. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J Am Soc Nephrol. 2015 Nov;26(11):2741-52. doi: 10.1681/ASN.2014090859. Epub 2015 Apr 9. PMID: 25858967; PMCID: PMC4625676.
In vivo protocol:
1. Shah BS, Chen M, Suzuki T, Embree M, Kong K, Lee CH, He L, Xiang L, Ahn JA, Ding S, Mao JJ. Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells. Sci Rep. 2017 Jan 27;7:36402. doi: 10.1038/srep36402. PMID: 28128224; PMCID: PMC5269584. 2. Lee HW, Khan SQ, Faridi MH, Wei C, Tardi NJ, Altintas MM, Elshabrawy HA, Mangos S, Quick KL, Sever S, Reiser J, Gupta V. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J Am Soc Nephrol. 2015 Nov;26(11):2741-52. doi: 10.1681/ASN.2014090859. Epub 2015 Apr 9. PMID: 25858967; PMCID: PMC4625676.
1: Shah BS, Chen M, Suzuki T, Embree M, Kong K, Lee CH, He L, Xiang L, Ahn JA, Ding S, Mao JJ. Pyrintegrin Induces Soft Tissue Formation by Transplanted or Endogenous Cells. Sci Rep. 2017 Jan 27;7:36402. doi: 10.1038/srep36402. PubMed PMID: 28128224; PubMed Central PMCID: PMC5269584. 2: Lee HW, Khan SQ, Faridi MH, Wei C, Tardi NJ, Altintas MM, Elshabrawy HA, Mangos S, Quick KL, Sever S, Reiser J, Gupta V. A Podocyte-Based Automated Screening Assay Identifies Protective Small Molecules. J Am Soc Nephrol. 2015 Nov;26(11):2741-52. doi: 10.1681/ASN.2014090859. Epub 2015 Apr 9. PubMed PMID: 25858967; PubMed Central PMCID: PMC4625676.